Triazolam

39 interactions 5 explained in plain English
Also sold as: Halcion
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Triazolam Acetaminophen And Codeine Capital® & Codeine Explained An increased risk of hypotension, respiratory depression, profound sedation, coma, and death Details Triazolam Buprenorphine Belbuca Explained An increased risk of CNS depression and respiratory depression Details Triazolam Aripiprazole Injection Abilify An increased risk of sedation and orthostatic hypotension Details Triazolam Butorphanol Injection Butorphic Increased risk of respiratory and CNS depression Details Triazolam Butorphanol Nasal Spray Stadol® NS Increased risk of respiratory and CNS depression Details Triazolam Cetirizine Injection Aller-Tec Increased risk of CNS depression Details Triazolam Cetirizine Ophthalmic Zerviate Increased risk of CNS depression Details Triazolam Diazepam Nasal Spray Valtoco Increased risk of CNS depression Details Triazolam Diazepam Rectal Diastat Increased risk of CNS depression Details Triazolam Encorafenib Braftovi Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Triazolam Esketamine Nasal Spray Spravato Increased risk of sedation Details Triazolam Fentanyl Transdermal Patch Duragesic® Increased risk of profound sedation, respiratory depression, hypotension, coma and death Details Triazolam Hydromorphone Injection Dilaudid Increased risk of respiratory and CNS depression Details Triazolam Hydromorphone Rectal available generically Increased risk of respiratory and CNS depression Details Triazolam Lacosamide Injection Motpoly An increased risk of CNS depression Details Triazolam Lefamulin Xenleta Increased sensitive CYP3A4 substrate exposure and an increased risk of sensitive CYP3A4 substrate-related toxicities associated wi... Details Triazolam Lenacapavir Injection Sunlenca Increased triazolam exposure Details Triazolam Lenacapavir Oral Sunlenca Increased triazolam exposure Details Triazolam Letermovir Injection Prevymis Increased CYP3A substrate exposure Details Triazolam Levodopa Oral Inhalation Inbrija An increased risk of CNS depression Details Triazolam Metoclopramide Injection Gimoti Increased risk of CNS depression Details Triazolam Metoclopramide Nasal Spray Gimoti Increased risk of CNS depression Details Triazolam Midazolam Nasal Spray Nayzilam Increased risk of hypoventilation, airway obstruction, desaturation, or apnea Details Triazolam Midazolam Injection Nayzilam Increased risk of hypoventilation, airway obstruction, desaturation, or apnea Details Triazolam Mitapivat Aqvesme Reduced CYP3A substrate exposure Details Triazolam Morphine Injection Astramorph® PF Increased risk of profound sedation, respiratory depression, hypotension, coma and death Details Triazolam Nalbuphine Injection Nubain® Increased risk of respiratory and CNS depression Details Triazolam Olutasidenib Rezlidhia Reduced sensitive CYP3A substrate exposure Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.